Cargando…

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer

BACKGROUND: Breast cancer remains a leading cause of cancer death worldwide. There is evidence that immunotherapy may play a role in the eradication of residual disease. Peptide vaccines for immunotherapy are capable of durable immune memory, but vaccines alone have shown sparse clinical activity ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dillon, Patrick M., Petroni, Gina R., Smolkin, Mark E., Brenin, David R., Chianese-Bullock, Kimberly A., Smith, Kelly T., Olson, Walter C., Fanous, Ibrahim S., Nail, Carmel J., Brenin, Christiana M., Hall, Emily H., Slingluff, Craig L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697108/ https://www.ncbi.nlm.nih.gov/pubmed/29157306 http://dx.doi.org/10.1186/s40425-017-0295-5

Ejemplares similares

Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data
por: Dillon, Patrick M, et al.
Publicado: (2020)

Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)
por: Slingluff, Jr., Craig L, et al.
Publicado: (2021)

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
por: Melssen, Marit M., et al.
Publicado: (2019)

Radiographically Occult Carcinomatous Spread of Breast Cancer to the Liver: A Challenging Case
por: Millard, Trish, et al.
Publicado: (2019)

Efficient dose-finding for drug combination studies involving a shift in study populations
por: Wages, Nolan A., et al.
Publicado: (2020)

A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes
por: Slingluff, Craig L, et al.
Publicado: (2014)

A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes
por: Dillon, Patrick M, et al.
Publicado: (2013)

A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes
por: Dillon, Patrick M, et al.
Publicado: (2014)

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
por: Meneveau, Max O, et al.
Publicado: (2021)

Treatment of breast fibroadenoma with high intensity focused ultrasound (HIFU): a feasibility study
por: Brenin, David
Publicado: (2015)

Anti-Yo Mediated Paraneoplastic Cerebellar Degeneration Associated with Pseudobulbar Affect in a Patient with Breast Cancer
por: Martin, Allison N., et al.
Publicado: (2017)

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma
por: Patel, Sapna P, et al.
Publicado: (2021)

Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)
por: Vavolizza, Rick D, et al.
Publicado: (2022)

Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function
por: Olson, Walter C, et al.
Publicado: (2011)

Paraneoplastic neurological complications of breast cancer
por: Fanous, Ibrahim, et al.
Publicado: (2016)

In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers
por: Caskey, M, et al.
Publicado: (2012)

A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
por: Ma, Cynthia X., et al.
Publicado: (2012)

Use of Mental Health Apps by Breast Cancer Patients and Their Caregivers in the United States: Protocol for a Pilot Pre-Post Study
por: Chow, Philip I, et al.
Publicado: (2019)

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
por: Mehrotra, Shikhar, et al.
Publicado: (2017)

Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis
por: Schaefer , Jochen T, et al.
Publicado: (2010)

Use of Mental Health Apps by Patients With Breast Cancer in the United States: Pilot Pre-Post Study
por: Chow, Philip I, et al.
Publicado: (2020)

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine
por: Mauldin, Ileana S, et al.
Publicado: (2015)

Delineation of anthracyclines and herceptin induced cardiotoxicity using contrast enhanced CMR
por: Hamirani, Yasmin S, et al.
Publicado: (2014)

Epicardium: interstitial Cajal-like cells (ICLC) highlighted by immunofluorescence
por: Suciu, L, et al.
Publicado: (2009)

A randomized multicenter Phase Ib/II study to assess the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab compared to CRT alone in resectable or borderline resectable pancreatic cancer
por: Katz, Matthew, et al.
Publicado: (2015)

Defining the effects of age and gender on clinical immune response to cancer vaccination
por: Ramirez, Adriana, et al.
Publicado: (2014)

Insights into the interstitium of ventricular myocardium: interstitial Cajal-like cells (ICLC)
por: Popescu, LM, et al.
Publicado: (2006)

Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas
por: Okada, Hideho, et al.
Publicado: (2013)

Interstitial Cajal-like cells (ICLC) in atrial myocardium: ultrastructural and immunohistochemical characterization
por: Hinescu, M E, et al.
Publicado: (2006)

Myocardial interstitial Cajal-like cells (ICLC) in caveolin-1 KO mice
por: Gherghiceanu, M, et al.
Publicado: (2009)

A distinct type of cell in myocardium: interstitial Cajal-like cells (ICLCs)
por: Kostin, S, et al.
Publicado: (2009)

Interstitial Cajal-like cells (ICLC) in myocardial sleeves of human pulmonary veins
por: Gherghiceanu, Mihaela, et al.
Publicado: (2008)

MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma
por: Engelhard, Victor H, et al.
Publicado: (2020)

Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events
por: Voges, Alessandra Rinah Nogueira, et al.
Publicado: (2021)

Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis
por: Sionov, Edward, et al.
Publicado: (2015)

Impact of comorbidities and treatment burden on general well-being among women’s cancer survivors
por: Anderson, R. T., et al.
Publicado: (2021)

Interstitial Cajal-like cells (ICLC) as steroid hormone sensors in human myometrium: immunocytochemical approach
por: Cretoiu, D, et al.
Publicado: (2006)

PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo
por: Aravantinou, Meropi, et al.
Publicado: (2016)

Myocardial interstitial Cajal-like cells (ICLC) and their nanostructural relationships with intercalated discs: shed vesicles as intermediates
por: Mandache, E, et al.
Publicado: (2007)

A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy
por: De Waele, Jorrit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qbhu0fn31et4l997ndtb19n1ge